DOCART
ActiveSummary
DOCART has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €345k and a net result of €91k. Equity is growing by ~46% per year across the filed fiscal years. Its solvency ranks better than 71% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
59
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. A confirmed filing finding caps the score. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability96▼-1
Solvency100▲+2
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €20k at 30 days only on tighter terms
Liquidity ample (current ratio 3.79 against 2.11 in 2023; short-term debt: 17.1% and cash: 54.4% of total assets), and 17.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
82.9%
Return on assets
22%
Age of the figures
21 mo
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-10-2025, 92 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 5 filingsDeviation from the deadline
2025
not confirmed
2024
92 d late
2023
15 d early
2022
84 d late
2021
92 d late
2020
90 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€345k▲ 36.0%
2023 · €254k
2020: €15k
2021: €122k
2022: €174k
2023: €254k
2020 → 2024
Total assets
€416k▲ 19.5%
2023 · €349k
2020: €300k
2021: €408k
2022: €321k
2023: €349k
2020 → 2024
Net result
€91k▲ 14.0%
2023 · €80k
2020: €13k
2021: €107k
2022: €52k
2023: €80k
2020 → 2024
Working capital
€198k▲ 117%
2023 · €91k
2020: €-225k
2021: €-88k
2022: €-7k
2023: €91k
2020 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€15k-€122k▲ 700%€174k▲ 42.5%€254k▲ 46.2%€345k▲ 36.0%
Operating result€18k-€143k▲ 706%€69k▼ 51.5%€106k▲ 52.7%€126k▲ 19.1%
Net result€13k-€107k▲ 706%€52k▼ 51.4%€80k▲ 54.8%€91k▲ 14.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 19% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €416k
Fixed assets
€147k ▼ 16.3%
Current assets
€269k ▲ 55.7%
Equity and liabilities €416k
Equity
€345k ▲ 36.0%
Debt
€71k ▼ 24.9%
Debt's share of the balance-sheet total falls from 27.2% to 17.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€163k▲
2023 · €141k
Cash flow
€128k▲
2023 · €115k
Current ratio
3.79▲
2023 · 2.11
Debt to equity
0.21▼
2023 · 0.37
ROE
26.5%▼
2023 · 31.6%
ROA
22.0%▼
2023 · 23.0%
Interest coverage
62.03▲
2023 · 44.13
Debt ≤ 1 year
€71k▼
2023 · €82k
Income taxes
€32k▲
2023 · €23k
Staff costs
€66k▲
2023 · €52k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 46 lines
Balance sheet
Code20232024
Assets
Total assets20/58€349k€416k▲
Fixed assets21/28€175k€147k▼
Intangible fixed assets21€137k€116k▼
Tangible fixed assets22/27€39k€30k▼
Plant, machinery and equipment23€8k€4k▼
Furniture and vehicles24€31k€26k▼
Current assets29/58€173k€269k▲
Amounts receivable within one year40/41€38k€42k▲
Trade receivables40€38k€42k▲
Cash at bank and in hand54/58€132k€226k▲
Deferred charges and accrued income490/1€3k€1k▼
Equity and liabilities
Total equity and liabilities10/49€349k€416k▲
Equity10/15€254k€345k▲
Contributions10/11€2k€2k=
Reserves13€150k€330k▲
Distributable reserves133€150k€330k▲
Profit (loss) carried forward14€102k€13k▼
Amounts payable17/49€95k€71k▼
Amounts payable after more than one year17€2k-
Financial debts170/4€2k-
Amounts payable within one year42/48€82k€71k▼
Current portion of amounts payable after more than one year42€4k€2k▼
Trade debts44€274€516▲
Suppliers440/4€274€516▲
Taxes, remuneration and social security45€46k€39k▼
Taxes450/3€41k€31k▼
Remuneration and social security454/9€4k€8k▲
Other amounts payable47/48€32k€30k▼
Accrued charges and deferred income492/3€11k-
Income statement
Code20232024
Remuneration, social security and pensions62€52k€66k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€35k€36k▲
Other operating charges640/8€548€505▼
Gross operating margin9900€194k€230k▲
Operating profit (loss)9901€106k€126k▲
Financial income75/76B€72€68▼
Recurring financial income75€72€68▼
Financial charges65/66B€3k€3k▼
Recurring financial charges65€3k€3k▼
Profit (loss) for the period before taxes9903€103k€124k▲
Income taxes67/77€23k€32k▲
Profit (loss) for the period9904€80k€91k▲
Profit (loss) for the period to be appropriated9905€80k€91k▲
Appropriation of the result
Profit (loss) to be appropriated9906€102k€193k▲
Profit (loss) brought forward from the previous period14P€22k€102k▲
Transfer to equity691/2-€180k
To other reserves6921-€180k
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
31-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 92 days late
2024
16-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity doublescurrent ratio 2.11
Current ratio from 0.95 to 2.11; short-term debt falls from €142k to €82k.
31-12
Financial
Equity above €200kEq €254k ▲46.2%
4 profitable years in a row build equity to €254k.
23-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 84 days late
2022
31-12
Financial
Equity above €150kEq €174k ▲42.5%
3 profitable years in a row build equity to €174k.
31-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 92 days late
2021
31-12
Financial
Highest result since 2020net €107k ▲706%
Operating result €143k, net result €107k, both a record.
31-12
Financial
Equity above €100kEq €122k ▲700%
2 profitable years in a row build equity to €122k.
29-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 90 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Grobbendonk · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Boudewijnstraat 52280 GrobbendonkGround area
619 m²
Building footprint
236 m²
Volume, LiDAR
1,471 m³
Parcel 13010B0308/00K000, Flanders · tallest building 11.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DOCART
since 20202.306.701.174
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13010B0308/00K000 | Flanders | 619 m² | 1 · 236 m² | 10.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DOKTER PHILIPPE ODEURS
BE 0739.824.641
Antwerpen · Eq €345,335
DOKTER J. LEYN
BE 0860.417.912
Brugge · Eq €345,103
Huisarts Roxane Vanderweeën
BE 0751.894.510
Denderleeuw · Eq €345,030
HUISARTSENPRAKTIJK BOGMAN - MORIAU
BE 0475.697.205
Essen · Eq €345,474
Cabinet médical Docteur DE CLERCK Antoine
BE 0810.904.756
Liège · Eq €345,606
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,156 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-08-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.